Literature DB >> 30018960

How Does the Epidemiology of Inflammatory Bowel Disease Differ between East and West? A Korean Perspective.

Suk-Kyun Yang1.   

Abstract

BACKGROUND: Though low compared with those in Western countries, the incidence and prevalence of inflammatory bowel disease (IBD) are rapidly increasing in Asia. If we could understand the differences in IBD epidemiology between Asian and Western countries, we might gain insights into the etiopathogenesis of IBD as well as guidance for personalized therapy.
SUMMARY: In Asia, unlike in the West, Crohn's disease (CD) predominantly occurs in men and involves a high prevalence of perianal fistulas. Moreover, in Korean CD patients, ileocolonic involvement is predominant, whereas isolated colonic involvement is very uncommon. In both ulcerative colitis (UC) and CD, extraintestinal manifestations, such as primary sclerosing cholangitis, as well as a positive family history of IBD are less frequent in Asian patients. However, as the prevalence of IBD rises in Korea, so does the frequency of a positive family history. While the colectomy rate among Korean UC patients is lower, the intestinal resection rate in CD patients is similar in Korea and in the West. Infectious problems that can adversely influence IBD management are usually more common in Asia. KEY MESSAGES: IBD in Asians differs from that in Westerners in many aspects, including demographic and clinical characteristics, prognosis, and associated problems.

Entities:  

Keywords:  East and West; Epidemiology; Inflammatory bowel disease; Korean perspective; Natural history

Year:  2017        PMID: 30018960      PMCID: PMC5988201          DOI: 10.1159/000454712

Source DB:  PubMed          Journal:  Inflamm Intest Dis        ISSN: 2296-9365


  76 in total

1.  The risk of colorectal cancer in ulcerative colitis: a meta-analysis.

Authors:  J A Eaden; K R Abrams; J F Mayberry
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

2.  Influence of a Positive Family History on the Clinical Course of Inflammatory Bowel Disease.

Authors:  Sung Wook Hwang; Min Seob Kwak; Wan Soo Kim; Jeong-Mi Lee; Sang Hyoung Park; Ho-Su Lee; Dong-Hoon Yang; Kyung-Jo Kim; Byong Duk Ye; Jeong-Sik Byeon; Seung-Jae Myung; Yong Sik Yoon; Chang Sik Yu; Jin-Ho Kim; Suk-Kyun Yang
Journal:  J Crohns Colitis       Date:  2016-03-01       Impact factor: 9.071

3.  Crohn's disease in Stockholm County during 1990-2001: an epidemiological update.

Authors:  Annika Lapidus
Journal:  World J Gastroenterol       Date:  2006-01-07       Impact factor: 5.742

4.  Risk of developing tuberculosis under anti-TNF treatment despite latent infection screening.

Authors:  Aranzazu Jauregui-Amezaga; Fanny Turon; Ingrid Ordás; Marta Gallego; Faust Feu; Elena Ricart; Julián Panés
Journal:  J Crohns Colitis       Date:  2012-06-05       Impact factor: 9.071

5.  Extracolonic diagnoses in ulcerative colitis: an epidemiological study.

Authors:  U Monsén; J Sorstad; G Hellers; C Johansson
Journal:  Am J Gastroenterol       Date:  1990-06       Impact factor: 10.864

6.  The epidemiology of inflammatory bowel disease: a large, population-based study in Sweden.

Authors:  A Ekbom; C Helmick; M Zack; H O Adami
Journal:  Gastroenterology       Date:  1991-02       Impact factor: 22.682

7.  Increasing incidence and lifetime risk of inflammatory bowel disease in Taiwan: a nationwide study in a low-endemic area 1998-2010.

Authors:  Chiao-Hsiung Chuang; Sheng-Hsiang Lin; Chiung-Yu Chen; Bor-Shyang Sheu; Ai-Wen Kao; Jung-Der Wang
Journal:  Inflamm Bowel Dis       Date:  2013-12       Impact factor: 5.325

8.  First prospective, population-based inflammatory bowel disease incidence study in mainland of China: the emergence of "western" disease.

Authors:  Jie Zhao; Siew C Ng; Yuan Lei; Fengming Yi; Jin Li; Limin Yu; Kaifang Zou; Zili Dan; Meng Dai; Yijuan Ding; Min Song; Qingtao Mei; Xiangming Fang; Huimin Liu; Zhaohong Shi; Rui Zhou; Ming Xia; Qingming Wu; Zhifan Xiong; Wencheng Zhu; Langiong Deng; Michael A Kamm; Bing Xia
Journal:  Inflamm Bowel Dis       Date:  2013-08       Impact factor: 5.325

9.  Risk Factors and Clinical Outcomes Associated with Cytomegalovirus Colitis in Patients with Acute Severe Ulcerative Colitis.

Authors:  Ho-Su Lee; Sang Hyoung Park; Sung-Han Kim; Jihun Kim; Jene Choi; Hyo Jeong Lee; Wan Soo Kim; Jeong-Mi Lee; Min Seob Kwak; Sung Wook Hwang; Dong-Hoon Yang; Kyung-Jo Kim; Byong Duk Ye; Jeong-Sik Byeon; Seung-Jae Myung; Yong Sik Yoon; Chang Sik Yu; Jin-Ho Kim; Suk-Kyun Yang
Journal:  Inflamm Bowel Dis       Date:  2016-04       Impact factor: 5.325

10.  Earlier surveillance colonoscopy programme improves survival in patients with ulcerative colitis associated colorectal cancer: results of a 23-year surveillance programme in the Japanese population.

Authors:  K Hata; T Watanabe; S Kazama; K Suzuki; M Shinozaki; T Yokoyama; K Matsuda; T Muto; H Nagawa
Journal:  Br J Cancer       Date:  2003-10-06       Impact factor: 7.640

View more
  11 in total

1.  Characteristics of adult patients newly diagnosed with Crohn's disease: interim analysis of the nation-wide inception cohort registry study of patients with Crohn's disease in Japan (iCREST-CD).

Authors:  Katsuyoshi Matsuoka; Toshimitsu Fujii; Ryuichi Okamoto; Akihiro Yamada; Reiko Kunisaki; Minoru Matsuura; Kenji Watanabe; Hisashi Shiga; Noritaka Takatsu; Shigeki Bamba; Yohei Mikami; Takayuki Yamamoto; Takahiro Shimoyama; Satoshi Motoya; Takehiro Torisu; Taku Kobayashi; Naoki Ohmiya; Masayuki Saruta; Koichiro Matsuda; Takayuki Matsumoto; Hiroshi Nakase; Atsuo Maemoto; Shinichiro Shinzaki; Yoko Murata; Shinichi Yoshigoe; Ayako Sasaki; Tsutomu Yajima; Tadakazu Hisamatsu
Journal:  J Gastroenterol       Date:  2022-08-05       Impact factor: 6.772

2.  The relationship between inflammatory bowel disease and Helicobacter pylori across East Asian, European and Mediterranean countries: a meta-analysis.

Authors:  Rabbiaatul Addawiyah Imawana; Daniel Robert Smith; Michaela Louise Goodson
Journal:  Ann Gastroenterol       Date:  2020-06-06

3.  Disease burden of inflammatory bowel disease in China from 1990 to 2017: Findings from the global burden of diseases 2017.

Authors:  Yan Qiu; Wen Ren; Ying Liu; Wei-Er Chen; Xiao-Hua Pan; Jing-Jing Ren
Journal:  EClinicalMedicine       Date:  2020-09-20

4.  Inflammatory bowel diseases: time of diagnosis, environmental factors, clinical course, and management - a follow-up study in a private inflammatory bowel disease center (2003-2017).

Authors:  D B Cury; R Oliveira; M S Cury
Journal:  J Inflamm Res       Date:  2019-05-28

Review 5.  Capturing the Biologic Onset of Inflammatory Bowel Diseases: Impact on Translational and Clinical Science.

Authors:  Dario Sorrentino; Vu Q Nguyen; Maithili V Chitnavis
Journal:  Cells       Date:  2019-06-06       Impact factor: 6.600

6.  The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.

Authors: 
Journal:  Lancet Gastroenterol Hepatol       Date:  2019-10-21

7.  Fecal lactoferrin accurately reflects mucosal inflammation in inflammatory bowel disease.

Authors:  Marrieth G Rubio; Kofi Amo-Mensah; James M Gray; Vu Q Nguyen; Sam Nakat; Douglas Grider; Kim Love; James H Boone; Dario Sorrentino
Journal:  World J Gastrointest Pathophysiol       Date:  2019-12-31

Review 8.  Update on the epidemiology of inflammatory bowel disease in Asia: where are we now?

Authors:  Sang Hyoung Park
Journal:  Intest Res       Date:  2022-04-29

9.  Carbon 60 Dissolved in Grapeseed Oil Inhibits Dextran Sodium Sulfate-Induced Experimental Colitis.

Authors:  Rayko Lazcano-Silveira; Xiaoxiao Jia; Kaixuan Liu; Honggang Liu; Xinrong Li; Mizhou Hui
Journal:  J Inflamm Res       Date:  2022-07-25

10.  Changes in the Long-term Prognosis of Crohn's Disease between 1986 and 2015: The Population-Based Songpa-Kangdong Inflammatory Bowel Disease Cohort Study.

Authors:  Byong Duk Ye; Sung Noh Hong; Seung In Seo; Ye-Jee Kim; Jae Myung Cha; Kyoung Hoon Rhee; Hyuk Yoon; Young-Ho Kim; Kyung Ho Kim; Sun Yong Park; Seung Kyu Jeong; Ji Hyun Lee; Hyunju Park; Joo Sung Kim; Jong Pil Im; Sung Hoon Kim; Jisun Jang; Jeong Hwan Kim; Seong O Suh; Young Kyun Kim; Sang Hyoung Park; Suk-Kyun Yang
Journal:  Gut Liver       Date:  2022-03-15       Impact factor: 4.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.